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ABSTRACT 
Bioassay-guided fractionation of the organic extract derived from the terrestrial 
fungus Penicillium coalescens led to the isolation of the known mycotoxin (-)-25 
botryodiplodin (1) and eight new structurally related analogues (2-9). Structures of the 
novel compounds were determined by MS and NMR studies, including 1D and 2D 
NMR. A likely biogenetic pathway from the aldehydic open form of 1 (C7 unit, U1), is 
proposed for these metabolites. Among of all the isolated metabolites, only (-)-1 
showed antifungal, antibacterial and insecticidal activity. According to our knowledge, 30 
this latter activity is a new property attributed to (-)-1. 
 
KEYWORDS: Penicillium coalescens, (-)-botryodiplodin, natural products, fungal 
metabolites, antifungal, antibacterial, insecticidal activity, Oncopeltus fasciatus, 
Ceratitis capitata.  35 
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INTRODUCTION 
Terrestrial fungi are a well recognized source for new bioactive metabolites (1), 
including various mycotoxins (2, 3). In the course of research aimed at finding new 
bioactive agents from fungi, the organic extract from the culture broth of the terrestrial 40 
fungus Penicillium coalescens (4) was seen to exhibit potent antifungal, antibacterial 
and insecticidal activities. The known mycotoxin (-)-botryodiplodin (1) and eight new 
related analogues (2-9) were isolated and identified by a bioassay-guided fractionation 
of the fungal extract, in which (-)-1 was found to be the most abundant compound 
(Figure 1). (-)-1 was isolated for the first time from Botryodiplodia theobromae Pat. 45 
(5), a fungus responsible for considerable damage in tropical plants (6), and was 
structurally elucidated by Arsenault et al. in 1969 (7). Afterwards, (-)-1 was found in 
other fungal species like P. roqueforti strain (6, 8, 9), P. stipitatum (10, 11), 
Macrophomina phaseolina (12) and others (13). In addition, P. roqueforti and M. 
phaseolina fungi have been reported as a contaminant of processed food (9) and the 50 
causal agent of numerous plant diseases (12), respectively. (-)-1 has received attention 
because of its potent antibiotic (5), antileukemic (14) and mutagen (15) activities as 
well as the ability to induce protein-DNA cross-links in mammalian cells (16-20) and to 
inhibit cell multiplication in growing cultures (21). It has been proposed that 
biogenetically, (-)-1 belongs to the polyketide pathway (22). Furthermore, several 55 
syntheses of (-)-1 and its derivatives have been reported (6, 23-35). 
Herein are depicted the isolation, structural elucidation and chemical structure 
relationships for the new analogues.  
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MATERIALS AND METHODS 60 
Chromatographic and Spectroscopic Analysis. TLC was run on silica gel F254 
precoated plates (Merck) and spots were detected under UV light. Isolation and 
purification were carried out by a Waters HPLC system with a 600 pump and both a 
2996 Photodiode Array Detector (PDA) and ELSD 2420 Detector (Milford, USA). 1H, 
13C, 1H-1H COSY and 1H-1H NOESY NMR spectra were recorded on a Bruker AV 300 65 
MHz instrument (Rheinstetten, Germany). Multiplicities of 13C signals were assigned 
by DEPT experiments. For HSQC, HMBC NMR experiments and NOEDIFF 
irradiations a Bruker 600 MHz (Rheinstetten, Germany) and a Varian Unity-400 MHz 
spectrometer were used. HRESMS (electrospray) data were carried out on a Micromass 
Q-TOF micro (Milford, USA). IR spectra were obtained with a 710FT 70 
spectrophotometer (Nicolet, Madison, Wisconsin, USA). Optical rotations were 
determined with a Perkin-Elmer 241 Polarimeter (Massachusetts, USA). 
Cultivation of P. coalescens. The fungal strain P. coalescens Quintanilla (CECT 
2766) was supplied by the “Colección Española de Cultivos Tipo (CECT)”. The strain 
of the fungus P. coalescens was seeded in Petri dishes containing PDA culture medium 75 
and incubated for 7 days at 28 ºC. Then, a solution of Tween 80 (0.05%) in sterile 
distilled water was used to obtain a suspension containing ca. 106 conidia/mL. This 
suspension was poured to an Erlenmeyer flask containing antibiotic test broth (1:9, v/v). 
The mixture was incubated with shaking (200 rpm) for 15 days, in the dark at 25 ºC. 
Extraction Process and Preliminary Fractionation. After incubation the mycelium 80 
was removed from the culture broth by filtration. Then, the broth (20 L) was partially 
evaporated in vacuum to 1 L and it was extracted with dichloromethane/ethyl acetate 
(1:1, v/v) (3 x 1 L). The resulting organic extract was dried (8.1 g) under reduced 
pressure and partitioned by flash column chromatography on silica gel (230-400 µm, 
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Merck) (1:80, w/w) using stepwise gradient elution from 75% hexane in ethyl acetate, 85 
100% ethyl acetate to 100% methanol. The volume eluted in each step was 2 L and 
thirteen fractions were obtained, evaporated to dryness and tested for biological 
activities. The dried mycelium (176 g) was firstly extracted with dichloromethane (3 x 1 
L) to give 0.25 g of dichloromethanic extract, and then with methanol (3 x 1 L) to 
obtain 13.5 g of methanolic extract. 90 
Isolation and Purification of Secondary Metabolites. The fraction F-IX was 
subjected to silica gel flash column chromatography using hexane/ethyl acetate (5:5, 
v/v) as mobile phase, obtaining an anomeric mixture of the (-)-botryodiplodin (1, 1.5g, 
18.52%). This major compound (-)-1 was not visible neither at λ 254 nm nor λ 365 nm 
and Cerium (IV) sulfate was employed for its visualization on the TLC plate. 95 
1H NMR spectra of F-II, F-III, F-IV and F-VI showed their structural similarity to (-
)-1. The most polar of these fractions, F-VI, was subjected to silica gel flash column 
using a gradient from 65% hexane in ethyl acetate to 100% ethyl acetate to give two 
promising subfractions 7 and 8. Second fractionation by silica gel column of the 
subfraction 8 afforded compound 2 (19.2 mg, 0.24%) while the subfraction 7 yielded 3 100 
(1.7 mg, 0.02%), by using as mobile phase hexane/ethyl acetate (8:2, v/v) and (7:3, v/v), 
respectively.  
The F-IV was purified by medium pressure flash chromatography (Biotage SP1 
coupled to an UV detector 254 λ) using a gradient from 100% hexane to 100% ethyl 
acetate. The subfraction 8 was subjected to a second silica gel column (hexane/ethyl 105 
acetate, 9:1, v/v) to give compound 4 (8.6 mg, 0.11%). The F-III was purified by silica 
gel column (hexane/ethyl acetate, 8:2, v/v) to afford compound 5 (18 mg, 0.22%) in the 
subfraction 3. Analysis of pure compounds was achieved via analytical RP-HPLC using 
a Tracer Excel ODSB C18 column, 4 µm (25.0 x 0.46 cm), eluting with a flow of 0.5 
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mL/min of acetonitrile/water (6:4, v/v) for 4 (tR= 22.1 min) and acetonitrile/water 110 
(7.5:2.5, v/v) for 5 (tR= 13.9 min). 
Finally, the less polar fraction, F-II, was subjected to silica gel flash chromatography 
using a gradient from hexane (with 2% triethylamine) to 100% ethyl acetate. The 
subfractions 2 and 6 were purified by semipreparative RP-HPLC using a Tracer Excel 
ODSB C18 column, 5 µm (25.0 x 1.0 cm) and eluting the mobile phase with a flow of 2 115 
mL/min. The subfraction 6 was eluted with acetonitrile/water (5:5, v/v) to afford 
compounds 6 (0.8 mg, 0.01%, tR= 32.4 min), 7 (0.7 mg, 0.009%, tR= 28.3 min) and 8 
(2.4 mg, 0.03%, tR= 26.1 min) while the subfraction 2 was run with acetonitrile/water 
(7:3, v/v) to give compound 9 (0.5 mg, 0.006%, tR= 19.8 min). 
Characterization of Compounds.  120 
(-)-Botryodiplodin dimer (2): [α]D25= -99.1º (c. 3.3, CHCl3); colourless oil; IR νmax 
2965, 2899, 1700, 1521, 1455, 1362 cm-1; HRESMS m/z 293.1360 [M+Na]+ 
(C14H22O5Na calc 293.1365). 1H NMR (300 MHz, CDCl3) δ 5.03 (1H, brs, H-2), 4.28 
(1H, t, J=8.7, Ha-5), 3.93 (1H, t, J=8.7, Hb-5), 3.54 (1H, m, H-4), 2.55 (1H, m, H-3), 
2.19 (3H, s, H-7), and 0.86 (3H, d, J=7.2, H-8) ppm; 13C NMR (75 MHz, CDCl3) δ 125 
206.19 (C-6), 105.42 (C-2), 67.09 (C-5), 53.39 (C-4), 41.93 (C-3), 30.23 (C-7), and 
12.42 (C-8) ppm.  
(+)-Botryodiplodinenone (3): [α]D25= +9.0º (c. 0.67, CHCl3); yellow oil; IR νmax 
2955, 2842, 1721, 1674, 1465, 1357 cm-1; HRESMS m/z 277.1415 [M+Na]+ 
(C14H22O4Na, calc 277.1416); 1H NMR (300 MHz, CDCl3) δ 6.09 (1H, s, Ha-6’), 5.81 130 
(1H, s, Hb-6’), 4.91 (1H, d, J=5.1, H-2), 4.25 (1H, dd, J=9.0, 6.3, Ha-5), 3.92 (1H, dd, 
J=9.0, 7.8, Hb-5), 3.69 (1H, dd, J=9.3, 6.0, Ha-5’), 3.30 (1H, dd, J=9.3, 6.0, Hb-5’), 
3.11 (2H, m, H-4’), 2.57 (1H, m, H-3), 2.34 (3H, s, H-1’), 2.20 (3H, s, H-7), 1.07 (3H, 
d, J=6.9, H-7’), and 0.93 (3H, d, J=7.2, H-8) ppm; 13C NMR (75 MHz, CDCl3) δ 208.57 
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(C-6), 199.92 (C-2’), 151.74 (C-3’), 125.06 (C-6’), 105.01 (C-2), 71.88 (C-5’), 67.73 135 
(C-5), 54.26 (C-4), 41.41 (C-3), 33.20 (C-4’), 30.05 (C-7), 26.53 (C-1’), 17.28 (C-7’), 
and 10.25 (C-8) ppm.  
(-)-Botryodioxandiendione (4): [α]D25= -39.0º (c. 10.3, CHCl3); colourless oil; IR 
νmax 2955, 2934, 1711, 1675, 1455, 1362 cm-1; HRESMS m/z 403.2103 [M+Na]+ 
(C21H32O6Na, calc 403.2097); 1H NMR (600 MHz, CDCl3) δ 6.13 (1H, s, Ha-6’), 6.06 140 
(1H, s, Ha-6”), 6.01 (1H, s, Hb-6’), 5.84 (1H, s, Hb-6”), 4.78 (1H, d, J=6.0, H-6), 4.60 
(1H, d, J=3.6, H-2), 3.88 (1H, dd, J=12.0, 0.5, Ha-4), 3.78 (1H, dd, J=12.0, 3.0, Hb-4), 
3.64 (1H, dd, J=9.0, 7.2, Ha-5”), 3.44 (1H, dd, J=9.0, 6.0, Hb-5”), 3.09 (2H, m, H-2’, 
H-4”), 2.54 (1H, m, H-5), 2.34 (6H, s, H-5’, H-1”), 1.44 (3H, s, H-9), 1.37 (1H, m, H-
4a), 1.11 (3H, d, J=6.9, H-7”) 1.10 (3H, d, J=6.9, H-1’), and 1.06 (3H, d, J=6.9, H-8) 145 
ppm; 13C NMR (75 MHz, CDCl3) δ 199.78 (C-2’’), 199.70 (C-4’), 151.47 (C-3’’), 
149.15 (C-3’), 126.61 (C-6’), 124.43 (C-6’’), 111.43 (C-6), 104.19 (C-7a), 98.85 (C-2), 
72.67 (C-5’’), 63.49 (C-4), 49.22 (C-4a), 39.04 (C-5), 37.53 (C-2’), 33.44 (C-4’’), 26.28 
(C-5’), 26.24 (C-1’’), 20.53 (C-9), 16.93 (C-7’’), 14.83 (C-8), and 13.52 (C-1’) ppm. 
(-)-2-Epi-botryodiplodinenone (5): [α]D25= -75.0º (c. 1, CHCl3); yellow oil; IR νmax 150 
2970, 2873, 1711, 1680, 1455, 1373 cm-1; HRMS m/z 277.1421 [M+Na]+ (C14H22O4Na, 
calc 277.1416); 1H NMR (300 MHz, CDCl3) δ 6.07 (1H, s, Ha-6’), 5.76 (1H, s, Hb-6’), 
4.70 (1H, s, H-2), 4.25 (1H, t, J=8.4, Ha-5), 3.87 (1H, t, J=8.4, Hb-5), 3.53 (1H, dd, 
J=15.9, 8.4, H-4), 3.44 (1H, dd, J=9.3, 7.2, Ha-5’), 3.32 (1H, dd, J=9.3, 5.7, Hb-5’), 
3.06 (1H, m, H-4’), 2.54 (1H, m, H-3), 2.33 (3H, s, H-1’), 2.17 (3H, s, H-7), 1.05 (3H, 155 
d, J=7.2, H-7’), and 0.81 (3H, d, J=7.2, H-8) ppm; 13C NMR (75 MHz, CDCl3) δ 206.90 
(C-6), 199.89 (C-2’), 151.80 (C-3’), 124.64 (C-6’), 109.51 (C-2), 71.66 (C-5’), 66.29 
(C-5), 53.85 (C-4), 42.24 (C-3), 33.18 (C-4’), 30.53 (C-7), 26.56 (C-1’), 17.26 (C-7’), 
and 12.93 (C-8) ppm. 
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(-)-4-Methyl-botryodioxanenone (6): [α]D25= -6.5º (c. 1.4, CHCl3); yellow oil; IR 160 
νmax 2925, 1677, 1458, 1172, 1082 cm-1; HRESMS m/z 277.1417 [M+Na]+ 
(C14H22O4Na, calc 277.1416). 1H NMR (600 MHz, CDCl3) δ 6.0 (1H, s, Ha-6’), 5.81 
(1H, s, Hb-6’), 5.36 (1H, d, J=4.5, H-7a), 4.75 (1H, d, J=4.8, H-2), 4.08 (1H, dd, J=8.5, 
6.6, Ha-6), 3.40 (1H, m, H-4), 3.36 (1H, m, Hb-6), 3.01 (1H, m, H-4’), 1.86 (1H, m, H-
5), 2.26 (3H, s, H-1’), 1.45 (1H, m, H-4a), 1.14 (3H, d, J=6.0, H-9), 1.04 (3H, d, J=7.2, 165 
H-5’), and 0.98 (3H, d, J=7.2, H-8) ppm; 13C NMR (75 MHz, CDCl3) δ 200.20 (C-2’), 
150.21 (C-3’), 126.19 (C-5’), 100.28 (C-7a), 96.75 (C-2), 73.46 (C-4), 72.59 (C-6), 
47.80 (C-4a), 38.02 (C-4’), 35.34 (C-5), 26.71 (C-1’), 20.45 (C-9), 19.80 (C-8), and 
14.19 (C-5’) ppm. 
(+)-4-Epi-methyl-botryodioxanenone (7): [α]D25= +3.9º (c. 0.7, CHCl3); yellow oil; 170 
IR νmax 2923, 1733, 1457, 1141 cm-1; HRESMS m/z 277.1420 [M+Na]+ (C14H22O4Na, 
calc 277.1416). 1H NMR (600 MHz, CDCl3) δ 6.01 (1H, s, Ha-6’), 5.83 (1H, s, Hb-6’), 
5.21 (1H, d, J=3.6, H-7a), 4.80 (1H, d, J=4.5, H-2), 4.19 (1H, t, J=8.4, Ha-6), 4.03 (1H, 
dd, J=13.5, 6.6, H-4), 3.41 (1H, t, J=8.4, Hb-6), 2.99 (1H, m, H-4’), 2.43 (1H, m, H-5), 
2.26 (3H, s, H-1’), 1.33 (1H, m, H-4a), 1.28 (3H, d, J=6.9, H-9), 1.03 (3H, d, J=7.2, H-175 
5’), and 0.97 (3H, d, J=6.6, H-8) ppm; 13C NMR (75 MHz, CDCl3) δ 200.16 (C-2’), 
149.92 (C-3’), 126.19 (C-6’), 99.79 (C-7a), 92.74 (C-2), 75.67 (C-6), 68.65 (C-4), 51.88 
(C-4a), 38.48 (C-4’), 33.42 (C-5), 26.70 (C-1’), 20.02 (C-9), 16.54 (C-8), and 14.19 (C-
5’) ppm. 
(-)-7a-Methyl-botryodioxanenone (8): [α]D25= -8.7º (c. 0.92, CHCl3); colourless oil; 180 
IR νmax 2960, 2929, 2853, 1736, 1496, 1455 cm-1; HRESMS m/z 277.1419 [M+Na]+ 
(C14H22O4Na, calc 277.1416); 1H NMR (300 MHz, CDCl3) δ 6.10 (1H, s, Ha-6’), 5.91 
(1H, s, Hb-6’), 4.62 (1H, d, J=6.0, H-2), 4.22 (1H, t, J=9.0, Ha-6), 3.98 (1H, dd, J=12.0, 
0.5, Ha-4), 3.82 (1H, dd, J=12.0, 3.0, Hb-4), 3.50 (1H, t, J=9.0, Hb-6), 3.06 (1H, m, H-
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4’), 2.67 (1H, m, H-5), 2.34 (3H, s, H-1’), 1.46 (3H, s, H-9), 1.33 (1H, m, H-4a), 1.11 185 
(3H, d, J=9.0, H-5’), and 1.08 (3H, d, J=6.0, H-8) ppm; 13C NMR (75 MHz, CDCl3) δ 
199.72 (C-2’), 149.40 (C-3’), 126.09 (C-6’), 105.41 (C-7a), 98.82 (C-2), 74.19 (C-6), 
63.93 (C-4), 50.06 (C-4a), 38.31 (C-4’), 33.31 (C-5), 26.28 (C-1’), 20.14 (C-9), 16.80 
(C-8), and 13.80 (C-5’) ppm. 
(+)-Ethoxyphenyl-botryodiplodin (9): [α]D25= +13.3º (c. 0.75, CHCl3); colourless oil; 190 
IR νmax 2955, 2929, 2852, 1721, 1500, 1450 cm-1; HRESMS m/z 271.1301 [M+Na]+ 
(C15H20O3Na, calc 271.1310), 1H NMR (300 MHz, CDCl3) δ 7.24 (5H, m, H-2’, H-6’), 
4.93 (1H, d, J=4.8, H-2), 4.21 (1H, dd, J=9.6, 6.6, Ha-5), 3.98 (1H, m, Ha-9), 3.93 (1H, 
m, Hb-5), 3.58 (1H, m, Hb-9), 3.09 (1H, m, H-4), 2.88 (2H, t, J= 6.6, H-10), 2.55 (1H, 
m, H-3), 2.12 (3H, s, H-7), and 0.95 (3H, d, J=7.8, H-8) ppm; 13C NMR (75 MHz, 195 
CDCl3) δ 207.82 (C-6), 139.13 (C-1’), 128.98 (C-6’, C-2’), 128.24 (C-5’, C-3’), 126.13 
(C-4’), 104.77 (C-2), 68.51 (C-9), 67.39 (C-5), 54.03 (C-4), 41.04 (C-3), 36.28 (C-10), 
29.29 (C-7), and 9.82 (C-8) ppm. 
Biological Assays. Insects Oncopeltus fasciatus Dallas and Ceratitis capitata 
Wiedemann were maintained at 27 ± 1ºC, 50-60% relative humidity and a 16h/8h 200 
(light/dark) photoperiod on a diet based on sunflower seeds and protein yeast autolysate 
(Aldrich, Spain) and sucrose in a 1:4 ratio. 
Target Microorganisms. Fungicidal activity was measured against 12 
phytopathogens: Verticillium dahliae (CCM 269), Aspergillus parasiticus (CECT 
2681), C. gloecesporoides (CECT 2859), Fusarium culmorum (CECT 2148), F. 205 
oxysporum ssp. gladioli (CCM 259), F. oxysporum ssp. niveum (CCM 259), P. italicum 
(CECT 2294), Phytophthora citrophthora (CECT 2353), Trichoderma viride (CECT 
2423), and Trichothecium roseum (CECT 2410). Six different bacterial strains were 
used to determine bactericidal activity: Bacillus cereus (CECT 148), Staphylococcus 
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aureus (CECT 86), Enterococcus faecalis (CECT 481), Salmonella typhi (CECT 409), 210 
Escherichia coli (CECT 405), and Erwinia carotovora (CECT 225). The strains were 
provided by the “Colección Española de Cultivos Tipo (CECT)” or by the “Colección 
de la Cátedra de Microbiología (CMM)” of the Biotechnology Department (Universidad 
Politécnica de Valencia).  
Entomotoxicity Activity. The entomotoxicity against O. fasciatus was carried out 215 
basically according to the contact method of Bowers et al. (36). It was evaluated by 
topical application to obtain either acute mortality (%) for the extract (100 µg/nymph) 
and fractions (25 µg/nymph) or LD50 values for the pure compounds. A total of 1 µL of 
the appropriate dilution in acetone was applied, using a micropipet, on the ventral 
surface of the abdomen of 10 newly moulted fourth-instar nymphs, which had 220 
previously been anesthetized with chloroform. After treatment, nymphs were confined 
in a 9 cm Petri dish with food and water provided ad libitum. Acute toxicity effects 
were considered according to the number of dead insects after 72 h of exposure to the 
chemicals. Controls were carried out in parallel and received the same amount of 
acetone as treated insects. All assays were conducted in triplicate. 225 
The entomotoxicity against C. capitata was evaluated by topical application (37) to 
obtain either acute mortality (%) for the extract (100 µg/fly) and fractions (25 µg/fly) or 
LD50 values for the pure compounds. A total of 1 µL of the appropriated dilution in 
acetone was applied, using a micropipet, on the ventral surface of the abdomen of 2-3-
day-old adult flies (five males and five females), which had previously been 230 
anesthetized with ice. Controls were similarly grouped, and each fly was treated with 1 
µL of acetone. After treatment, the flies were placed into a methacrylate box (10 x 10 x 
10 cm) that contained a circular hole (6 cm in diameter) covered with a net cloth, and 
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diet and water were provided ad libitum. Mortality was assessed at intervals of 24 h for 
10 days in triplicate. 235 
Antifungal and Antibacterial Activities. These assays were determined in triplicate 
by the paper disk-agar diffusion assay according to Cole (38). The dose of the assays 
were at 100 µg/mm2 (2 mg/disk) for organic extracts, at 50 µg/mm2 (1 mg/disk) for the 
fractions and at 10 µg/mm2 (0.2 mg/disk) for pure compounds. The fungal strains were 
seeded in Petri dishes containing PDA culture medium and incubated for 7 days at 28 240 
ºC. Then a solution of Tween 80 (0.05%) in sterile distilled water was used to obtain a 
suspension containing ca. 106 conidia/ mL. 1 mL of this conidia suspension was added 
to 15 mL of PDA in a Petri dish. After the solidification, four Wathman disks (nº 113, 
0.5 cm diameter) impregnated with the tested products, at appropriate doses, were added 
in these Petri dishes. PDA plates containing disks impregnated only with the solvent 245 
used to dissolve the tested compounds were used as negative controls, and disks with 
benomyl (methyl-1-[butylcarbamoyl]-2-benzymidazolecarbamate; Sigma), at different 
concentrations according to the fungus species assayed, were used as positive controls. 
Fungicidal activity was determined measuring the inhibition zone developed around the 
paper disk indicating a zone of no growth.  250 
In the bactericidal tests, cultures of 24 h of each bacterium, maintained in inclined 
tubes on solid culture medium, were reactivated with a Nutrient Broth (Difco) and were 
incubated for 24 h at 28 ºC or 37 ºC, according to the bacterium. Then, 1 mL of this 
suspension was inoculated in a Petri plate, and 15 mL of culture medium Plate Count 
Agar (Difco) were added. When the medium was completely solidified, five paper disks 255 
loaded with the tested products were placed in the dish. These plates were incubated for 
24 h in the dark at 28ºC or 37ºC, according to the bacterium. Plate Count Agar plates 
containing disks impregnated only with the solvent used to dissolve the tested 
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compounds were used as negative controls, and a positive control with tetracycline 
chlorhydrate (10 μg/cm2) was performed to appraise the level of activities. Bactericidal 260 
activity was determined measuring the halo developed around the paper disk. 
Statistical Analysis. Probit analysis (39) was used to determine the LD50 values. 
Results of χ2 analysis for goodness of fit for the regression equation revealed existence 
of considerable homogeneity in the data. Analysis of variance (ANOVA) was 
performed for fungicidal and bactericidal data (Table 1) and the least significant 265 
difference (LSD) test was used to compare means (Statgraphics plus 5.1 version). 
 
RESULTS AND DISCUSSION 
Elucidation of Metabolites. The molecular formula C7H12O3 of (-)-1 was 
determined by ESMS that showed the ions at m/z 167.1 [M+Na]+  and 127.1 [M+1-270 
H2O]+ and it was identified as an inseparable anomeric mixture (α/β, 65:35) by 
comparison of its MS, 1H and 13C NMR with the data reported (8). F-IX was treated 
with Ac2O in pyridine giving in a quantitative yield the 2,3-trans-botryodiplodin acetate 
(7), confirming the structure of (-)-1. It was obtained as a colourless oil and according to 
precedent literature (-)-1 has the property of turning the skin pink after 2-3 h following 275 
application (14). 
The (-)-botryodiplodin dimer (2) was identified in view of its ESMS, 1H and 13C 
NMR data. Its NMR signals practically overlapped with those of (-)-1 and its HRESMS 
gave an [M+Na]+ ion of m/z 293.1360 (calcd 293.1365 for C14H22O5Na), indicating a 
molecular formula containing twice the number of carbon and proton atoms as were 280 
observed in its NMR spectra. From these data we deduced that the compound (-)-2 must 
be a symmetrical dimer of (-)-1. In addition, the acetylation reaction of (-)-2 was 
unsuccessful, indicating the absence of a free hydroxyl group. In accordance with the 
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absolute configuration of (-)-1, previously determined by crystal X-ray analysis (8) and 
the coupling constant value J2,3= 0 Hz, indicating a trans relationship between H-2 and 285 
H-3 (6, 40), a (2S,2’S,3R,3’R,4S,4’S)-2 configuration was established.  
(-)-2-Epi-botryodiplodinenone (5) showed a 1H NMR spectra very similar to (-)-1, 
and its HRESMS showed an [M+Na]+ ion of m/z 277.1421 (C14H22O4Na, calc 
277.1416) suggesting the presence of the furan core linked to other C7 fragment (C-1’ to 
C-7’). Given that the C-6’ (δ 124.64) was correlated in the HSQC spectrum to two 290 
proton resonances at δ 6.07 and 5.76, an olefinic methylene contained into this C7 
fragment was proposed. Analysis of the 2D NMR spectra revealed that the linkage 
between this C7 moiety and botryodiplodin core was at hydroxyl group in C-2 since 
HMBC correlations were observed from the H-2 (δ 4.70) to C-5’ (δ 71.66). 
Furthermore, assuming that the stereogenic centres of the parent compound (-)-(3R,4S)-295 
1 were fixed through the likely biogenetic pathway, the configurations of the carbons C-
4, C-3 and C-4’ remain determined. Also, the multiplicity of H-2 as a singlet (J2,3= 0 
Hz) pointed out a trans coupling with H-3 (6, 40). The absolute configuration could be 
suggested as (2R,3R,4S,4’R)-5, which could be corroborated by NOESY correlations of 
H-2 (δ 4.70) to H-8 (δ 0.81) showing that H-2 and H-8 were orientated on the same 300 
side. 
(+)-Botryodiplodinenone (3) was elucidated on the basis of the great similarity 
between its 1H and 13C NMR spectra with compound (-)-5. In addition, compound (+)-3 
also gave the same [M+Na]+ ion in HRESMS, m/z 277.1415 (C14H22O4Na, calc 
277.1416). The unique major variation in 1H NMR of (+)-3 was the multiplet at δ 3.11 305 
integrating for two protons that through COSY and HSQC experiments it was assigned 
to H-4 and H-4’. The 13C NMR contained a significant difference in C-2 which suffered 
a strong shielding (δ 105.01 for (+)-3 vs 109.51 for (-)-5). Also, a doublet (d, J2,3=5.1 
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Hz) corresponding to the multiplicity of H-2 (δ 4.91) was indicative of a cis relationship 
between H-2 and H-3 (δ 2.57) (6, 40). Therefore, the inspection of the MS, 1D and 2D 310 
NMR showed that compound (+)-3 is an epimer of (-)-5 in position 2 with a 
(2S,3R,4S,4’R)-3 configuration.  
HRESMS of (-)-7a-methyl-botryodioxanenone (8) gave an [M+Na]+ ion m/z 
277.1419 that established the molecular formula as C14H22O4Na (calc 277.1416). Its 
resemblance with 1H and 13C NMR data of (-)-1 indicated that it was a new membership 315 
into this group bearing a 3-methylenepentan-2-one moiety, probably provided from a C7 
unit. COSY and HMBC correlations showed the presence of an AMX system at δ 4.22 
(Ha-6) and 3.50 (Hb-6), and 2.67 (H-5) as well as a second ABX system at δ 3.98 (Ha-
4) and 3.82 (Hb-4), and 1.33 (H-4a). The characteristic signal of H-4a was correlated in 
HSQC to the relatively upfield carbon at δ 50.06, pointing out that this methine could be 320 
involved in a constrained system like on the bridge of a fused bicycle. Two highly 
deshielded sp3 carbons at δ 105.41 (C-7a) and 98.82 (C-2) were suitable to carbons 
between two oxygen atoms. In view of the correlations provided by HMBC from the C-
2 (δ 98.82)  to H-4’ (δ 3.06) and H-5’ (δ 1.11) as well as COSY correlations between H-
2 and H-4’, indicated that the connectivity of the C7 unit to the tetrahydrofuro[2,3-325 
d][1,3]dioxane core was on the acetalic carbon C-2. Configurations of C-5, C-4a and C-
4’ were suggested as (R), (S) and (R), respectively according to the biogenetic pathway. 
In order to determine the stereochemistry of the rest of stereocentres, NOEDIFF 
experiments were carried out. Signal enhancement of H-4a (δ 1.33, m) upon irradiation 
of H-9 (δ 1.46, s) was observed, while irradiation of H-2 (δ 4.62, d) affected to H-9 (δ 330 
1.46, s) and H-4’ (δ 3.06, m), enabling to suggest a (2R,4aS,5R,7aR,4’R)-8 
configuration.  
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Analysis of spectral data of (-)-botryodioxandiendione (4) proved that it was an 
analogue of compound (-)-8, attached to another 5-hydroxy-4-methyl-3-methylene-
pentan-2-one moiety (C7 unit). HMBC experiment showed correlations from the H-6 335 
resonance (δ 4.78) to carbon C-5” (δ 72.67) revealed the link between C-6 of 
tetrahydrofuran core and the terminal alcohol of the newly included C7 unit. The 
configurations of C-5, C-4a, C-2’ and C-4” were set according to its biogenetic pathway 
as (5R,4aS,2’R,4”R) and the coupling constant value J5,6=6.0 Hz determined a cis 
relationship between H-5 and H-6 (6, 40). Unfortunately, compound 4 was chemically 340 
unstable suffering facile degradation and making its NOE studies inaccessible, therefore 
the stereogenic centers C-7a and C-2 could not be determined.  
The structure of (-)-4-methyl-botryodioxanenone (6) was elucidated by means of its 
1D and 2D NMR spectra. 1H NMR signals and COSY revealed the tetrahydrofuro[2,3-
d][1,3]dioxane core attached to the 4-methyl-3-methylenepentan-2-one framework (C7 345 
unit). In 13C NMR, both the presence of a unique methylene and the absence of 
quaternary carbons on the bicycle differenced this new compound of its structural 
isomer (-)-8. Two methine groups highly deshielded at  δ 4.75 and 5.36 were detected 
and assigned to H-2 and H-7a, respectively. COSY correlations from the H-4a (δ 1.45) 
to H-7a (δ 5.36) and H-4 (δ 3.40), from H-5 (δ 1.86) to H-8 (δ 0.98), and from H-4 to 350 
H-9 (δ 1.14) were observed, establishing the H-9 on position 4 of the 1,3-dioxane ring. 
The stereochemistry of C-5, C-4a and C-4’ was fixed through its biogenetic route as 
(5R,4aR,4’R), while both the coupling constant J7a,4a=4.5 Hz and the NOESY 
correlations of H-4a to H-7a determined a cis ring junction (6, 40). Finally, the NOESY 
correlations of H-2 (δ 4.75) to H-4 (δ 3.40), and H-4 (δ 3.40) to H-4a (δ 1.45) showed 355 
they were orientated on the same side, suggesting a feasible (2S,4S,4aR,5R,7aS,4’R)-6 
configuration.  
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In view of 1D and 2D NMR spectra of (+)-4-epi-methyl-botryodioxanenone (7), an 
steroisomer of compound (-)-6 was proposed. The great difference in 1H NMR was the 
deshielding experimented by H-4 (δ 4.03 for (+)-7 vs 3.40 for (-)-6) and H-5 (δ 2.43 for 360 
(+)-7 vs 1.86 for (-)-6). Similar to compound (-)-6, the biogenetic route, the coupling 
constant J7a,4a=3.6 Hz and NOESY correlations of H-4a (δ 1.33) to H-7a (δ 5.21), 
determined a cis ring junction and a (5R,4aR,4’R) stereochemistry (6, 40). In addition, 
NOESY correlations of H-4 (δ 4.03) to H-8 (δ 0.97), H-2 (δ 4.80) to H-7a (δ 5.21) and 
H-9 (δ 1.28), H-7a (δ 5.21) to H-9 (δ 1.28) and finally, H-5 (δ 2.43) to H-4a (δ 1.33) 365 
allowed us to propose a (2S,4R,4aR,5R,7aS,4’R)-7 configuration.  
1D and 2D NMR spectra of (+)-ethoxyphenyl-botryodiplodin (9) revealed a 
molecule of (-)-1 connected to a phenylethyl fragment on its hydroxyl group. HMBC 
correlations from C-2 (δ 104.77) to Hb-9 (δ 3.58) confirmed this hypothesis. The 
multiplicity of H-2 (δ 4.93) as a doublet (J2,3=4.8 Hz) indicated a cis relationship 370 
between H-2 and H-3 (δ 2.55) (6, 40). Taking into account the known configuration of 
(-)-botryodiplodin and the relative stereochemistry between H-2 and H-3, the absolute 
configuration may be assigned as (2S,3R,4S)-9. 
Chemical Structure Relation Between Metabolites. It was concluded that except 
for (-)-2 and (+)-9, which are clearly derivatives of 1, all the new identified structures 375 
(3-8) seem to be formed from the resultant open form of the hemiacetal (-)-1 (C7 unit, 
U1). This unit U1 might be reactive enough to undergo different reaction sequences 
(Figure 2). In order to determine that compounds 3-8 were not formed from (-)-1 during 
the purification procedures, it is highlighted that the initial TLC of the organic extract 
from the broth already showed the metabolite profile, in which no changes were 380 
observed after successive chromatographies. In addition, (-)-1 was dissolved in ethyl 
acetate, treated with silica gel (1:80, w/w) and stirred overnight at room temperature, 
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after which both the TLC and 1H NMR of the residue showed no evidence of the 
botryodiplodin analogues (3-8). 
We propose chemical structure relationships between (-)-1 and the other metabolites 385 
3-8, that might also coincide with a possible biogenetic pathway (Figure 2). On the one 
hand, the aldehydic open form of the hemiacetal (-)-1, C7 unit U1, is able to suffer a 
reaction sequence of dehydration (U2)/ reduction to yield a molecule C7 unit U5, which 
could react with the hemicetal (-)-1 leading to compounds (+)-3 and (-)-5, or could react 
with the aldehyde U1, giving an intermediate that undergoes intramoleculat ring closure 390 
to obtain compound (-)-4. On the other hand, the aldehyde U1 enables a sequence of 
reduction (U3)/ oxidation (U4)/ intramolecular ring closure/ reduction (ketone function) 
giving a dihydroxy derivative which after reaction with an aldehyde U2 can yield to the 
acetalic compounds (-)-6 and (+)-7. Also the unit U3 could undergo intramolecular ring 
closure to provide other dihydroxy derivative which could react with an aldehyde U2 to 395 
obtain the compound (-)-8. In summary, a common C7 unit (U1) resulted from the 
parent compound (-)-1 may lead via a likely biogenetic pathway to a novel family of 
botryodiplodin analogues. 
Biological Assays of the Organic Extracts, Fractions and Isolated Compounds. 
Biological assays of the extracts were performed, and only the organic extract from the 400 
culture broth exhibited acute antifungal, antibacterial and insecticidal activities (Table 
1). Neither the dichloromethanic extract nor the methanolic extract of the mycelium 
showed biological activity. For the antifungal and antibacterial assays, the fractions F-I 
to F-XIII, were only tested against those strains that initially had been the most sensitive 
to the extract: P. citrophthora, V. dahliae, S. aureus and S. typhi. After performing 405 
biological assays of the all fractions, the F-IX was found to be the uniquely bioactive 
and all the activities were determined for the compound (-)-1 (Table 2). In the course of 
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our research focused on finding new insecticidal agents, the compounds (-)-
botryodiplodin dimer (2), (-)-2-epi-botryodiplodinenone (5) and 2,3-trans-
botryodiplodin acetate were also submitted to test against O. fasciatus (Table 3). The 410 
other compounds were isolated in an insufficient quantity to perform biological trials.  
In conclusion, biological assays showed that (-)-botryodiplodin (1) was the 
responsible for the potent antifungal, antibacterial and insecticidal activities displayed 
by the organic extract from the fungus P. coalescens. The other tested metabolites (2, 5 
and botryodiplodin acetate) were not active in the insecticide assays. In accordance to 415 
other authors (6), it might pointed out that the free hydroxyl function of (-)-1 seems to 
be essential for its activity, probably due to its open hemiacetal form with the aldehydic 
function as the active agent.  
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Figure 1. Natural Metabolites (1-9) from P. coalescens. 
Figure 2. Chemical Structure Relationships of Botryodiplodin Analogues 3-8. 
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Inhibition zone (mm) 72h (means ± SE)a 
Broth organic extractb Benomyl 
F.culmorum 21.33 ± 0.88A 19.00 ± 0.58A,c1 
F.oxysporum niveum 7.67 ± 0.33A 17.33 ± 0.88B,c2 
F.oxysporum gladioli 11.66 ± 0.33A 9.33 ± 0.88A,c1 
V.dahliae 56.33 ± 2.02B 20.00 ± 1.15A,c3 
P.citrophthora 38.67 ± 1.33B 18.67 ± 0.88A,c4 
C.gloesporoides 29.67 ± 0.88A 26.67 ± 0.88A,c5 
T.roseum 11.33 ± 0.33A 29.67 ± 0.88B,c2 
T.viride 0 ± 0A 12.33 ± 0.88B,c6 
A.parasiticus 7.67 ± 0.33A 8.33 ± 0.33A,c6 
P.italicum 10.67 ± 0.33A 16.67 ± 0.33B,c7 
Bacterial strains 
Bactericidal activity 
Inhibition zone (mm) 24h (means ± SE)a 
Broth organic extractb Tetracycline chlorhydrated 
B.cereus 13.33 ± 0.88A 18.33 ± 0.33B 
S.aureus 19.00 ± 0.57B 16.67 ± 0.33A 
E.faecalis 28.33 ± 0.88A 31.67 ± 0.88A 
S.typhii 28.67 ± 0.33B 18.67 ± 1.20A 
E.coli 21.33 ± 0.33A 24.00 ± 1.15A 
E.carotovora 35.67 ± 1.33A 34.67 ± 1.45A 
Insects Insecticidal activity % acute mortality 72h 
O.fasciatus 100 ± 0e1 
C.capitata 100 ± 0e2 
 
a Each value represents the average and the standard error of three independent 
experiments. Whithin each line mean values labelled with the same superscript (A-B) 
do not present statistically significant differences (P > 0.05). b dose: 2 mg/disk. c1 dose: 
10 µg/disk; c2 dose: 5 µg/disk; c3 dose: 0.25 µg/disk; c4 dose: 1.5 µg/disk; c5 dose: 0.5 
µg/disk; c6 dose: 1 µg/disk; c7 dose: 0.2 µg/disk. d dose: 0.2 mg/disk. e1 dose: 100 
µg/nymph; e2 dose: 100 µg /fly. 
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Table 2. Biological Activities of the Fraction F-IX and the Pure Compound (-)-




Inhibition zone (mm) 72h (means ± SE)a 
FIXb (-)1c Benomyl 
V.dahliae >25.00 17.31 ± 1.02 14.32 ± 1.11d1 
P.citrophthora >25.00 8.21 ± 0.88 17.13 ± 1.22d2 
Bacterial strains 
Bactericidal activity 
Inhibition zone (mm) 24h (means ± SE)a 
FIXb (-)1c Tetracycline chlorhydratec 
S.typhii 22.11 ± 0.12 16.23 ± 0.82 24.21 ± 0.24 








O.fasciatus 100 ± 0e1 5.55 ± 0.45 
C.capitata 93.33 ± 6.66e2 12.90 ± 0.66g 
 
a Each value represents the average and the standard error of three independent 
experiments. b dose: 1 mg/disk. c dose: 0.2 mg/disk. d1 dose: 0.25 µg/disk; d2 dose: 1.5 
µg/disk. e1 dose: 25 µg/nymph; e2 dose: 25 µg/fly. f values in μg/nymph, were 
determined 72 h after exposure to the chemical. g The death of the population was 100% 
males. 
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slope LD50 (95% CL)b χ2 df p 
Botryodiplodin 6.52 ± 1.65 5.75 (4.60, 6.57) 3.54 4 0.47 
Botryodiplodin acetate 4.60 ± 1.09 12.19 (9.21, 14.36) 1.56 6 0.95 
Botryodiplodin dimer - >15.00 - - - 
2-Epi-botryodiplodinenone - >15.00 - - - 
 
a Regression analysis, linear model: y=ax+b; log dose vs probit mortality. 
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